Usefulness of PET-CT for Invasive Fungal Infection

Launched by PUERTA DE HIERRO UNIVERSITY HOSPITAL · Jan 15, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the use of a special imaging test called 18F-FDG PET-CT to help doctors better understand and manage invasive fungal infections, which are serious infections caused by fungi. The researchers want to find out if using this imaging test can provide more detailed information about the infection compared to traditional imaging methods. They hope it will help doctors make better decisions about treatment and improve patient outcomes.

To be eligible for the trial, participants need to be at least 18 years old and admitted to the hospital with a diagnosis of an invasive fungal infection. They must also be able to undergo one 18F-FDG PET-CT scan and give their consent to participate. If you join the study, you will receive the PET-CT scan as part of your care, and researchers will compare the results from your scan to those of patients who do not have the test. This trial is currently recruiting participants, and it aims to provide valuable insights into how to better manage these challenging infections.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • 18-year-old adult patients
• • who are admitted with a diagnosis of invasive fungal infection
• • who able to undergo a one 18F-FDG PET-CT
• • who give their informed consent.
• Exclusion criteria:
• • concomitant active bacterial infection likely to produce uptake in organs and tissues
• • recent surgery in the area of the IFI (in the previous 3 months)
• • other medical conditions that interfere with the development of the study ( e.g., inability to tolerate the performance of the test during the required time, pregnancy)
• • terminal situation.